Artículos sobre 23andMe

Mostrando todos artículos

Genetic testing is available to people who want to know if they carry a variant of a gene that confers susceptibility for Alzheimer’s. But knowing whether to get tested is hard. Billion Photos/Shutterstock.com

Genetic testing: Should I get tested for Alzheimer’s risk?

Alzheimer's is not only the third leading cause of death in the U.S. but also the most dreaded diagnosis. Genetic testing can help determine susceptibility, but knowing whether to test isn't easy.
Genetic testing for breast cancer gene mutations is now available. But it could lead to over treatment. Fotos593/Shutterstock.com

As genetic testing for breast cancer gene mutation expands, questions arise about treatment decisions

A genetics testing company recently won approval from the FDA to market a test that can identify a breast cancer gene mutation. But what are women supposed to do with that information? There's risk involved.
DNA peddling needs to be banned. home_of_chaos

It is game over for 23andMe, and rightly so

The market for personal genome services is facing a reality check. While the most prominent and innovative company 23andMe has flourished so far, in the past few years many of its competitors have gone…
Welcome to nowhere, says FDA. widdowquinn

Stopping 23andMe will only delay the revolution medicine needs

Genetic testing is a powerful tool. Two years ago, with the help of my colleagues, it was this tool that helped us identify a new disease. The disease, called Ogden Syndrome, caused the death of a four-month…

Principales colaboradores

Más